Pneumonia — an infection of one or both of your lungs — can leave you coughing, feverish and feeling miserable. And sometimes, it can land you in the hospital struggling to breathe.

On July 15, 2024, CAPVAXIVE ™ (Pneu-C-21) was authorized for use in Canada for the prevention of invasive pneumococcal disease caused by Streptococcus pneumoniae in adults 18 years of age and older.

That superbug, Klebsiella, is increasingly resistant to antibiotics and can cause pneumonia, wound infections and even meningitis in patients it infects. Professor Trevor Lithgow, the lead on the ...

Infections from Mycoplasma pneumoniae, the bacteria that can cause walking pneumonia, are common, with about 2 million cases in the United States every year; they typically affect youths age 5 to 17.

The Centers for Disease Control and Prevention has warned of an unusual increase in bacterial infections caused by Mycoplasma pneumoniae. But what exactly is it and why is it concerning?

The increase was highest among children. For 5- to 17-year-olds, the rate of M. pneumoniae diagnoses, as a percentage of all pneumonia-related emergency room visits, surged from 3.6 percent to 7.4 ...

† VIMs are made up of 266 amino acid residues with the exception of VIM-7 (265 residues) and VIM-18 (262 residues). VIM-21, -22 and -27 have been assigned in the Lahey Clinic [201], but there ...